Cargando…

The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma

Malignant glioma represents a fatal disease with a poor prognosis and development of resistance mechanisms against conventional therapeutic approaches. The distinct tumor zones of this heterogeneous neoplasm develop their own microenvironment, in which subpopulations of cancer cells communicate. Ada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuss, Anna Maria, Groos, Dominik, Buchfelder, Michael, Savaskan, Nicolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197239/ https://www.ncbi.nlm.nih.gov/pubmed/34073734 http://dx.doi.org/10.3390/ijms22115518

Ejemplares similares

MCT4 Promotes Tumor Malignancy in F98 Glioma Cells
por: Reuss, Anna Maria, et al.
Publicado: (2021)

Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
por: Savaskan, Nicolai E., et al.
Publicado: (2015)

Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema
por: Sehm, Tina, et al.
Publicado: (2016)

Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2015)

Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas
por: Ackermann, Annemarie, et al.
Publicado: (2017)

The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
por: Chen, Daishi, et al.
Publicado: (2017)

Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment
por: Hatipoglu, Gökçe, et al.
Publicado: (2015)

Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2012)

Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death
por: Ackermann, Annemarie, et al.
Publicado: (2021)

Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration
por: Wolf, Ines M. L., et al.
Publicado: (2014)

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis
por: Fan, Zheng, et al.
Publicado: (2014)

Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency
por: Yakubov, Eduard, et al.
Publicado: (2016)

Brain Miffed by Macrophage Migration Inhibitory Factor
por: Savaskan, Nic E., et al.
Publicado: (2012)

A new functional classification system (FGA/B) with prognostic value for glioma patients
por: Friedlein, Katharina, et al.
Publicado: (2015)

The impact of dietary isoflavonoids on malignant brain tumors
por: Sehm, Tina, et al.
Publicado: (2014)

Blue-light treatment reduces spontaneous and evoked pain in a human experimental pain model
por: Reuss, Anna Maria, et al.
Publicado: (2021)

The Glycolytic Switch in Tumors: How Many Players Are Involved?
por: Yu, Li, et al.
Publicado: (2017)

Glycolytic Switch in Response to Betulinic Acid in Non-Cancer Cells
por: Heiss, Elke H., et al.
Publicado: (2014)

A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain
por: Ghoochani, Ali, et al.
Publicado: (2015)

Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis
por: Ghoochani, Ali, et al.
Publicado: (2016)

Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
por: Nabavi, Noushin, et al.
Publicado: (2016)

Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy
por: Chang, Howard T, et al.
Publicado: (2013)

Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2016)

Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance
por: Li, Na, et al.
Publicado: (2020)

Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
por: Sehm, Tina, et al.
Publicado: (2016)

PRG3 induces Ras-dependent oncogenic cooperation in gliomas
por: Fan, Zheng, et al.
Publicado: (2016)

A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes
por: Bingxiang, Xiao, et al.
Publicado: (2021)

Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma
por: Catalano, Myriam, et al.
Publicado: (2022)

Targeting the Complement Pathway in Malignant Glioma Microenvironments
por: Zhu, Hongtao, et al.
Publicado: (2021)

DDOST Correlated with Malignancies and Immune Microenvironment in Gliomas
por: Chang, Xiaojing, et al.
Publicado: (2022)

Methylglyoxal in the Brain: From Glycolytic Metabolite to Signalling Molecule
por: Yang, Zeyong, et al.
Publicado: (2022)

Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes
por: Long, Niya, et al.
Publicado: (2020)

Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas—Challenges and Perspectives
por: Kaminska, Bozena, et al.
Publicado: (2021)

Epigenetics in Brain Tumors: HDACs Take Center Stage
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2016)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Updates on the WHO diagnosis of IDH-mutant glioma
por: Reuss, David.E.
Publicado: (2023)

Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
por: Lee, Su Yeon, et al.
Publicado: (2016)

Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas
por: Caffo, Maria, et al.
Publicado: (2023)

Tumor Microenvironment in Glioma Invasion
por: Tamai, Sho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qo0ha44evevtmalh1tfuon50p4